|
Early vs no recurrence in endocrine therapy group
|
---|
|
Univariate analysis
|
p Value
|
Multivariate analysis
|
p Value
|
---|
ALDH1, ≤1 %/>1 %
|
1.804 (0.651–4.609)
|
0.244
|
Not selected
| |
Age, ≤50/>50 years
|
0.996 (0.526–1.932)
|
0.992
|
Not selected
| |
Tumor size, ≤20/>20 mm
|
6.182 (3.208–12.383)
|
<0.001
|
4.910 (2.469–10.076)
|
<0.001
|
Nodal metastasis negative/positive
|
3.344 (1.543–7.181)
|
0.002
|
2.894 (1.229–6.777)
|
0.002
|
Progesterone receptor staining, <20 %/≥20 %
|
0.708 (0.382–1.313)
|
0.272
|
Not selected
| |
Ki-67 staining, <20 %/≥20 %
|
1.441 (0.619–3.159)
|
0.383
|
Not selected
| |
Tumor grade 1 or 2/3
|
2.615 (1.666–4.128)
|
<0.001
|
2.820 (1.296–6.111)
|
<0.001
|
-
ALDH1 aldehyde dehydrogenase 1